Triple-negative breast cancers (TNBCs) are characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, and account for about 15% of all invasive breast cancers [1]. Here, ESR1 is linked to invasive breast carcinoma.